Share this
Poseida Therapeutics Enters Strategic Collaboration and License Agreement With Roche
Immatics Enters Global Exclusive License Agreement With Bristol Myers Squibb
Poseida Therapeutics Enters Research Collaboration With Takeda to Develop Novel Gene Therapies
Merus Enters Collaboration With Eli Lilly to Develop New Generation of Cancer Treatments
Talis Biomedical – $254 Million IPO
Hansa Biopharma Announces Collaboration with Sarepta
Poseida Therapeutics – $224 Million IPO
Therachon Sells to Pfizer for up to $810 Million
Lodo Therapeutics Enters $970 Million Multi-Target Collaboration With Genentech
Selecta Biosciences – $74 Million IPO
AveXis – $95 Million IPO
Cardioxyl Pharmaceuticals sale to Bristol-Myers Squibb
NewLink Will License Ebola Vaccine to Merck
FORMA $600 Million Collaboration with Celgene
TYRX: Acquired by Medtronic
Two Independent Billion-Dollar Life Sciences Collaborations
Apollo Endosurgery Agreement Acquire Obesity Intervention Division of Allergan
FORMA Therapeutics $200M Strategic Collaboration Deal with Celgene
Cylex Use Chapter 11 Bankruptcy to Achieve Exceptional Sale Price